- Investing Ideas
- South Korean Pharmaceuticals & Biotech Sustainable Track Record
South Korean Pharmaceuticals & Biotech Sustainable Track Record
Results
6
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
6 companies
PharmaResearch
Market Cap: ₩4.1t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩393,000.00
7D
-5.8%
1Y
-41.8%
Samsung BiologicsLtd
Market Cap: ₩71.6t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,518,000.00
7D
-5.7%
1Y
-3.6%
Oscotec
Market Cap: ₩1.4t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩36,600.00
7D
-2.1%
1Y
8.6%
JW Shinyak
Market Cap: ₩117.3b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩2,215.00
7D
-2.9%
1Y
51.1%
JW Holdings
Market Cap: ₩286.1b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩4,025.00
7D
-0.9%
1Y
20.7%
SK Biopharmaceuticals
Market Cap: ₩6.8t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩84,500.00
7D
-6.6%
1Y
-13.5%